Publications by authors named "M Pless"

Claim this Profile
C
Clinical characteristics, healthcare resource use, and survival outcomes among patients with advanced NSCLC tested for KRAS mutations in France, the United Kingdom, and Switzerland.
Marie Wislez, Andromachi Giannopoulou, Isabelle Borget, Colin Lindsay, Sacha I Rothschild, Miklos Pless

J Med Econ· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled analysis of the SAKK trials 16/96, 16/00, 16/01, 16/08 and 16/14.
L Frehner, S Schär, S Hayoz, M Guckenberger, T Finazzi, M Pless

ESMO Open· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy.
Dominic Schmid, Bettina Sobottka, Massimiliano Manzo, Marta Trüb, Katharina Leonards, Miklos Pless

Nat Commun· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in Patients With Resectable Stage III NSCLC Who Did Not Have Definitive Surgery After Neoadjuvant Treatment-A Retrospective Analysis of the SAKK Trials 16/96, 16/00, 16/01, 16/08, and 16/14: A Brief Report.
Sabine Raimann, Sämi Schär, Stefanie Hayoz, Matthias Guckenberger, Tobias Finazzi, Miklos Pless

JTO Clin Res Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optic Nerve and Optic Nerve Sheath Biopsy Indications and Outcomes.
Reilly A Coombs, John J Chen, Diva R Salomão, Deena A Tajfirouz, Eric R Eggenberger, Misha L Pless

J Neuroophthalmol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis